Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Short-term Investments of $13.0 million for Q4 2025, up 193.02% year-over-year from $4.4 million in Q4 2024, and down 7.74% quarter-over-quarter from $14.1 million in Q2 2025.

Analysis

Sol-Gel Technologies (SLGL) Short-term Investments (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Short-term Investments for 10 consecutive years, with $13.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Short-term Investments rose 193.02% year-over-year to $13.0 million; the TTM figure through Dec 2025 stood at $13.0 million (up 193.02% YoY), while the FY2025 annual figure was $13.0 million, up 193.02% from the prior year.
  • Short-term Investments slipped to $13.0 million in Q4 2025 per SLGL's latest filing, from $14.1 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $21.0 million in Q2 2022 and bottomed at $1.7 million in Q4 2021.
  • Historically, Short-term Investments has averaged $13.7 million across 5 years, with a median of $14.5 million in 2024.
  • Annual changes were most pronounced in 2021 — Short-term Investments plunged 92.11% — and 2022, when it jumped 407.78%.
  • Sol-Gel Technologies' Short-term Investments stood at $1.7 million in 2021, then surged by 407.78% to $8.7 million in 2022, then soared by 135.9% to $20.5 million in 2023, then tumbled by 78.38% to $4.4 million in 2024, then soared by 193.02% to $13.0 million in 2025.
  • Business Quant data shows SLGL's Short-term Investments at $13.0 million in Q4 2025, $14.1 million in Q2 2025, and $4.4 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.27 Mn
Mar 31, 2026 42.69 Mn
Dec 31, 2025 12.97 Mn
Sep 30, 2025 12,000.00
Jun 30, 2025 12,000.00
Mar 31, 2025 12,000.00
Dec 31, 2024 4.43 Mn
Sep 30, 2024 14.63 Mn
Jun 30, 2024 14.91 Mn
Mar 31, 2024 5.01 Mn
Dec 31, 2023 20.47 Mn
Sep 30, 2023 12.00 Mn
Jun 30, 2023 13.50 Mn
Mar 31, 2023 8.50 Mn
Dec 31, 2022 8.68 Mn
Sep 30, 2022 17.00 Mn
Jun 30, 2022 21.00 Mn
Mar 31, 2022 9.00 Mn
Dec 31, 2021 1.71 Mn
Sep 30, 2021 2.24 Mn